chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna first dose and Pfizer second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Moderna first dose and Pfizer second dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Moderna first dose and Pfizer second dose). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Moderna first dose and Pfizer second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided by the reporter. No treatment information provided   Reporter did not allow further contact
Within 24 hrs nausea, temps between 100 degrees - 101 degrees for 3 days, arm sore and hard, arm blotchy looking, diarrhea, headache. Now at day 6, fever gone, but arm still sore and blotchy Evening of day 1 slept 12 hours. Still tired.
12/16/22 presents to ED for "shortness of breath". PMHx of "ILD, cerebral atherosclerosis".
SHE RECEIVED HER 2ND DOSE 12 DAYS AFTER HER FIRST DOSE
6NOV96 & 7NOV96 t105 w/red facial rash (small red dots);
Patient is a 76 y.o. female patient of, MD with history of HTN, HLD, DM Type II, osteoarthritis, secondary adrenal insufficiency, RUL metastatic melanoma, asthma who presented to Hospital with generalized weakness and fatigue.   Covid-19 Virus Infection Date of onset of symptoms: 5/16/2023 Symptoms present on admission: generalized weakness, fatigue, cough, chills Date of covid positive test: 05/18/2023           Vaccination status: vaccinated Anticipated special isolation end date: 05/26/2023 Initially was on cefepime and vancomycin, discontinued on 5/19 Patient started on remdesivir on 5/19 per ID recommendations  IV remdesivir and dexamethasone in the hospital I discussed with Dr. recommendation no need for patient to finish IV remdesivir course as long as oxygen stable on room air and no symptoms Discharge home   Acute Hypoxemic Respiratory Failure CTA pulmonary arteries on 5/19/2023: negative for PE, aortic dissection. Interval decrease in size of ovoid mass in the medial suprahilar, nonspecific hilar and mediastinal adenopathy. Currently requiring room air Wean as tolerated maintaining O2 sats >90. Breathing treatment as needed  urine strep/legionella antigen negative sputum culture in progress ,MRSA DNA amplified probe.  Negative Patient initially required oxygen via nasal cannula 3 to 4 L, currently oxygen stable on room air   Malignant Melanoma of the RUL  Metastasis to brain.  Managed by Dr.   Consult oncology, pending evaluation Last treatment on 4/20/2023.   Immunotherapy induced hypophysitis Secondary adrenal insufficiency Continue Levothyroxine Solucortef increased to 30mg in AM/20mg in afternoon due to acute illness Consult endocrinology, recommendations stress dose of hydrocortisone while patient receiving IV remdesivir for COVID-19, resume outpatient dose if stable when remdesivir is discontinued   Mild hyponatremia with sodium 133 might be related to dose of hydrocortisone and poor oral intake Osmolality 283 Possibly related to poor oral intake Gentle hydration initially then discontinued Endocrinology consult, recommended stress dose of hydrocortisone while the patient on IV remdesivir   Obesity due to excessive calories Weight loss Imaging: CTA pulmonary arteries Oxygen requirements on admission: room air Current oxygen requirements: Room air Medical therapy: steroids, remdesivir Consultants following: oncology; infectious disease Anticipated special isolati
Fever 104 degree (R) seizure - tonic - clonic, 8 times for < 3 minutes.
This medically confirmed health authority report (initial receipt 15-Dec-2014) concerns a female patient. Her concomitant medication included NUVARING. The patient had medical history of allergy to diphenhydramine and azithromycin. On an unspecified date, the patient received influenza (seasonal) vaccine (manufacturer and batch number not reported) and pneumococcal vaccine (manufacturer and batch number not reported). On an unspecified date, the patient developed stiffness, fever, nausea and chills. The outcome was not reported. Linked case: 2014047580 (same patient).
No adverse reactions as of yet.  Client in to walk in clinic requesting FIRST dose of Moderna.   She denied getting any other covid vaccines on her paperwork and reported this as her first dose.  Once she was vaccinated and a profile was created in out system, the state registry reported that she has had a dose of Janssen on 4/6/2.  We asked her if that was indeed true, she said yes and then said her doctor was encouraging her to get the Moderna series since she had "only had the J&J".  I explained to her that we would not be giving her the second Moderna and that it goes against the current recommendations and processes here with the Health Department.  She left prior to her 15 minutes but did not verbalize or show any adverse reactions during the time she was here.
Moderate allergic reaction; itchy skin; itchy eyes; Headache; This is a spontaneous report from a contactable consumer. An 80-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 9263), via an unspecified route of administration in right arm on 24Jan2021 11:45 at a single dose for COVID-19 immunization. Medical history included Diabetes2, HiBloodPress and HiCholesterol. Concomitant medication included lisinopril, simvastatin, and unspecified diabetes medication. On 26Jan2021, the patient experienced moderate allergic reaction, itchy skin, itchy eyes and headache. The patient was taking antihistamines with some relief for moderate allergic reaction, itchy skin, itchy eyes. There was no treatment for headache. The outcome of the events was recovering. Prior and since the vaccination, the patient was not tested for COVID-19. The events were assessed as non-serious.
Mother called in two hours after injection.  Child crying pointed to foot and bottom lip and chin quivering and body shivering motion.  Brought to office, MD feels no adverse reaction to injection.
Nausea and vomiting starting when waking up day after vaccine; seen in EMD, better w/Zofran, discharged home
Pronounced and swollen lymph nodes on right side of neck, along clavicle/ collar bone
Suspected vaccination faliure; autism; Guillain-Barré syndrome; flu symptoms; other unspecified problems; This case was reported by a nurse via call center representative and described the occurrence of vaccination failure in an unspecified number of patients who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), autism (serious criteria GSK medically significant), guillain barre syndrome (serious criteria GSK medically significant), flu symptoms and adverse reaction. On an unknown date, the outcome of the vaccination failure, autism, guillain barre syndrome, flu symptoms and adverse reaction were unknown.   It was unknown if the reporter considered the vaccination failure, autism, guillain barre syndrome, flu symptoms and adverse reaction to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, he had seen thousands of patients over the years that had reported many, unspecified problems after getting a flu vaccine.  He gave example like, sometimes patients said that after getting a flu vaccine, they had developed autism, Guillain-Barre syndrome or flu symptoms and many other unspecified problems. The reporter further added, his facility required that the patients get the flu vaccine, so a patient cant be dying of sepsis but they have to get the flu vaccine in the emergency department. No other details were provided other than what was documented at time of initial report. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation for influenza were not provided. The reporter consented to follow up. This case is one of the three cases, reported by the same reporter.
Patient presented to ED on 2/26/22 with right hemiplegia, CT head found a left basal ganglia hemorrhage. Follow-up imaging studies and a recent cerebral angio  performed on 9/22/22, failed to reveal evidence of any aneurysm, early venous drainage, nidus, dissection, vasculitis, vasospasm or tumor blush was identified which would explain her spontaneous ICH.
Had pre-menopausal symptoms.  missed period, hot flashes. Had labs drawn and estrogen was slightly low
allergic reaction; swelling of the tongue; swelling of the tongue and lips; This case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number ZJ432, expiry date 27th May 2022) for prophylaxis.   On 29th October 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 29th October 2020, less than a day after receiving Shingrix, the patient experienced allergic reaction, swollen tongue and lip swelling. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the allergic reaction, swollen tongue and lip swelling were not recovered/not resolved.   It was unknown if the reporter considered the allergic reaction, swollen tongue and lip swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced an allergic reaction that included swelling of the tongue and lips, after receiving the 1st dose of the Shingrix vaccine. Vaccine was given in the left deltoid on 29th December 2020 at 2pm .  The patient was instructed to take Benadryl for the swelling. As of 3pm, the swelling was going down.  When the reporter last spoken to the patient at 4pm the swelling has gone down.  Thus far, there had been no follow-up with the patient. The reporter consent to follow up.
I now have Leukocytoclasia vasculitis (LCV) which took me 10 months, 17 doctors, 7 specialists, multiple misdiagnosis, and 2 unnecessary irreversible surgeries to finally diagnose me. My quality of life has been horrible. I can't walk or stand for long periods of time, travel without major issues, I can't do any physical activities including dancing, cleaning around the house or walking quickly up the stairs of my home, cannot wear even 1 inch heels, and have to wear shoes to support my feet due to the extreme level of pain, swelling and discomfort. I am often stuck in bed and having to be carried to the restroom or have a caretaker assist with getting me what I need. I was not even able to visit more than two dress shops yesterday to try on wedding dresses without swelling up and having horrendous bumps and Red rashes all over my legs. I was previously a very active 38 year older who, ran, danced, skated, and was a fashionista that lived for my heels, but my new world is that I can't even get around my 3 story home, can't walk my dog on most days, can't even stand to cook in the kitchen or do normal things. I'm miserable and am bringing this to your attention after speaking to someone at V safe check-in and being disregarded as if it wasn't to do with my vaccine now only to find out it is after eliminating my mild case of Crohns which has been in remission for several years. Time occurrence has built from once a month to always always.
It was reported that a female pt rec'd TTOX-tetanus Toxoid absorbed vaccination on 7/20/00. Approx 2 days later the pt developed a 3 inch by 31/2 inch local reaction at the site of injection. Further information requested. From additional correspondence rec'd on9/21/00, it was reported. Reviewed no additional information at this time. No further information is expected. This case is closed.
I've have an IUD for 3 years and I irregularly very lightly spot for a day or two every few months.  I was vaccinated Monday afternoon and by Tuesday night I started bleeding.  To put it into perspective I generally use 1 panty liner a day of the usually 2 maybe 2 days I lightly spot.  But I have been using 6 or so panty liners a day since then and it's Thursday night.  So this is highly irregular for my regularity.   I aldo expelled blood clots which hasn't happened since I had the IUD placed.  I thought it should be reported.
34 y/o pt reports the occurrence of a red, raised slightly itchy rash that began within a day or two after receiving his first anthrax vaccination on 10May04. The rash occurred mostly on his torso-back, abdomen and chest with a few on his arms and legs. He denies any SOB, fatigue, HA, joint or muscles pains. He sought medical care on 27May04 and was treated with OTC cortisone preparation. He also reports having a somewhat sore knot the size of a quarter on his left arm @ injection site that lasted about a week. He received no other injections that day or during the previous month and has never had an adverse reaction to any vaccines received in the past.
No adverse outcomes.  Pt was born which makes her 17 years and 11 months old.
lethargic; did not feel well for a "day or so/not feeling that great; tiredness; This spontaneous case was reported by a patient and describes the occurrence of LETHARGY (lethargic), MALAISE (did not feel well for a "day or so/not feeling that great) and FATIGUE (tiredness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A, 012M20A, 051F21A and 01M21A) for COVID-19 prophylaxis.     Concomitant products included ATORVASTATIN and METOPROLOL for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargic), MALAISE (did not feel well for a "day or so/not feeling that great) and FATIGUE (tiredness). At the time of the report, LETHARGY (lethargic), MALAISE (did not feel well for a "day or so/not feeling that great) and FATIGUE (tiredness) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, Heart rate: patient documented a Pulse of 85. On 06-Feb-2021, Heart rate: had a slightly elevated pulse for 12 hours.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had a high pulse for 1 day after 1 dose of moderna primary series. On 13 January 2021 the patient documented a Pulse of 85. The patient was documenting his own pulse rates. Patient did not feel well for a day or so.  On 06 February 2021 the patient received his second Moderna primary series dose and had a slightly elevated pulse for 12 hours. Patient did not feel well for 24 to 36 hours. Patient reported not feeling that great tiredness, lethargic.  Patient reported not feeling that great tiredness and lethargic after monovalent booster first and second dose.  No treatment medication details were provided.   This case was linked to MOD-2023-694310 (Patient Link).
Post vax, the pt developed reactive inguinal lymphadenopathy in right thigh. Mild lymphocytosis and mild thrombocytosis.
w/in 3 hrs of inject pt c/o nausea, abdo pain, body aches, dizziness & chills; no local react @ inject site; lasted about 20 hrs; temp unk;
I had a mildly sore arm. I was fatigued and feeling flu like. Body ache and fatigue headache and low grade fever. I took Tylenol it was okay. The next day I was shaky tired and fatigued, on 04-01-2021. I had to take a nap on the 04-03-2021, I woke up with diarrhea and had uncontrollable bowl movements in my own fecal matter. I had extreme fatigue. I started passing out and fainting. I went to the doctor, I went to the doctor and was diagnosed with Autonomic Dysfunction. After the first three weeks of the vaccine, I was having low blood pressure dizziness, and passing out on the ground. At times it felt like my skin was crawling. I was having problems regulating my body temperature. I could not get through a day because of the extreme. I am now taking B12 injections. I'm currently not passing out after four B12 injections. I am taking twice the amount of allergy medications to function throughout the day. Over the last months since August I have had two rounds of prednisone. I also have been diagnosed with mass cell since being vaccinated.
At 07:30 am, Friday, October 8th, I was heading to work. I walk to school. As I was exiting my door, I noticed my chest and back were hurting. And I am 61 and it had been a long week and I was sort of attributing it to normal work fatigue. As the morning progressed, I continued to have some low level chest and back pain. At about 10:30, with students, I was getting a bit sweaty. The attention in my brain - as to whether this was serious or trivial event was beginning to dominate over being able to talk to students. I went to school nurse. 9-1-1 was called. I was transported by ambulance to Hospital. Elevated Troponin - indicative of heart damage. At this point, with the additional information I now I have, I know that that event was a heart attack. I will have open heart surgery soon - will move a couple of arteries around. So there is permanent issues surrounding it. Treatment at this time: Nitroglycerin patches and sublingual. Heparin drip IV also. There is another medicine - a blood pressure med that I wasn't on before. I think it's one of the beta blockers. I am on oxygen right now. Bedrest and time at the hospital while waiting for surgery.
Information has been received from a physician and a healthcare worker referring to unspecified number of patients of unknown ages and gender. On unspecified dates since 05-FEB-2015 the patiens were vaccinated with improperly stored doses of GARDASIL (lot #, strength, dosage and route unspecified), which were exposed to temperatures outside of the recommended range. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a nurse, for GARDASIL, a Pregnancy Registry product, concerning a 17 year old female patient with no pertinent medical history and no known drug allergies who on 29-JUL-2009 was vaccinated IM with a 0.5 ml dose of GARDASIL (lot number 661953/1130X). There was no concomitant medication. The patient was pregnant when received the dose, the last menstrual period (LMP) approximately on 30-MAY-2009. There was no adverse event reported. On an unspecified date the patient saw a doctor. There were no lab studies performed. At the time of the report, the outcome of the patient was not reported. Follow-up information received from the nurse concerning the female with no history of previous pregnancy who on 29-JUL-2009 was vaccinated with a dose of GARDASIL (lot number 661953/1130X). The LMP of the patient was 31-MAR-2009 (previously reported as approximately 30-MAY-2009). On 15-SEP-2009 an ultrasound was performed for no prenatal care, which resulted in live intrauterine. The estimated delivery date is 14-DEC-2009. On 23-DEC-2009 the patient's labor was induced with CERVIDIL for postdate pregnancy. On 24-DEC-2009, 41 weeks and 3 days from the LMP, the patient gave birth to a 7 pounds 15.7 ounces weight normal baby (sex unspecified). The Apgar score was 8 at 1 minute and 9 at 5 minutes. The patient had episiotomy and 3 degree extension during labor/delivery. PITOCIN was used. Additional information is not expected.
Client was admin. TST with 0.1 cc ID Left F/A. She later called and stated that within 30 minutes she had "shooting pain in left elbow from outer bone to inner arm". She was referred to her MD and her MD diagnosed the reaction as an allergic reaction to PPD solution. No meds that would have C/I the TST, pt states she has "health issues and many allergies". Appeared stable and alert immed. following the TST.
Patient called me at the pharmacy on the morning  of Saturday (4-20-19) to say that her arm was red and swollen at the injection site and warm to the touch.  I then advised her to go to a clinic  to get it checked out to be on the safe side.  She came back with a prescription for an antibiotic ( Bactrim DS) which I filled and dispensed.  I then found out that 3 days later her arm still wasn't improving so she sought additional medical attention.  This time she was given prescriptions for a Medrol Dose Pak and Loratadine.  After these meds were finished I thought that everything had been resolved.  Then on 7-1-19 I received another call from the pt stating that she was still having  issues that she felt was related to the shot ( rosacea and joint pain).  So I thought best to report all of the information I was presented with.
pt experienced delayed body rash on back/arms/legs- beginning 7/5/21- advised pt to try Benadryl and consult with physician regarding 2nd dose of Moderna
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 10-FEB-2016 the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) (lot # L024250, expiration date 30-JUN-2017, dosage and route not specified). It was reported that the vaccine was stored at -13.7 degree centigrade for 15 hours. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Grandma stated patient had headache within 3 minutes and started fever and sore throat on Saturday 101 temp, Motrin given.  Other kids in household received nasal and did not have any problems.
5 days after receiving the vaccine I began to wheeze.  I've never had a problem with wheezing before.   This has continued  and I had to be prescribed an albuterol inhaler.
The left arm injection site became more sore and itchy and a red rash below the injection site.
Information received on 08MAY2015 from a health care provider. An individual of unspecified gender and age received a fourth dose of BIOTHRAX (Lot unknown) two months early.  No further information was provided. Additional information requested. Sender's Comments: Inappropriate schedule reported; no adverse event; not assessable.
Headache; Fever; Chills; Muscle ache; Feeling nauseous; This is a spontaneous report from a non-contactable consumer (parent of the patient).   A female patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 06:30 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache, fever, chills, muscle ache, on an unspecified date. These symptoms were gone on unspecified date. On unspecified date the patient has been feeling nauseous all day, with outcome of unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.